Recommending a plant-based diet
Dr. Jan Hajek (biography, no disclosures) What I did before As an infectious disease physician, I was concerned about the public health threats posed by animal agriculture. The emergence of...
View ArticleIncretin Safety: What is the Evidence?
Breay W. Paty, MD, FRCPC (biography and disclosures) Disclosures Dr. Paty has received speaking fees and/or sat on advisory boards for Merck, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Abbott,...
View ArticleDiabetes and exercise
Andrew Farquhar MD (biography and disclosures) What I did before As a GP with a special interest in Diabetes and a long-term firm believer in the benefits of regular exercise it’s fair to say I devote...
View ArticleClik here to view.
This app changed my practice: Pocket A1C
Dr. Steve Wong (biography and disclosures) Editor’s note: The use of smartphones and mobile, handheld computing devices like the iPhone, iPod Touch and others among physicians is remarkable. In 2011,...
View ArticleNew targets for Diabetes (A1C): Why we are aiming at 'only' 7 percent
Dr. Breay W. Paty (biography and disclosures) What I Did Before Tight glucose control (reflected in A1C), reduces the risk of microvascular complications, such as retinopathy, nephropathy and...
View ArticleWhat are the CV risks of TZDs: have the safety questions been answered?
Breay W. Paty, MD, FRCPC (biography and disclosures) Update September 23, 2010: The FDA has announced severe restrictions on the access to Avandia in the United States. Current users of Avandia who are...
View ArticleRecommending a plant-based diet
Dr. Jan Hajek (biography, no disclosures) What I did before As an infectious disease physician, I was concerned about the public health threats posed by animal agriculture. The emergence of...
View ArticleIncretin Safety: What is the Evidence?
Breay W. Paty, MD, FRCPC (biography and disclosures) Disclosures Dr. Paty has received speaking fees and/or sat on advisory boards for Merck, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Abbott,...
View ArticleDiabetes and exercise
Andrew Farquhar MD (biography and disclosures) What I did before As a GP with a special interest in Diabetes and a long-term firm believer in the benefits of regular exercise it’s fair to say I devote...
View ArticleThis app changed my practice: Pocket A1C
In response to reader requests and the increasing interest in mobile apps, we are launching a series of articles highlighting useful iPhone apps. These will appear approximately once every three months.
View ArticleNew targets for Diabetes (A1C): Why we are aiming at ‘only’ 7 percent
Dr. Breay W. Paty (biography and disclosures) What I Did Before Tight glucose control (reflected in A1C), reduces the risk of microvascular complications, such as retinopathy, nephropathy and...
View ArticleWhat are the CV risks of TZDs: have the safety questions been answered?
Breay W. Paty, MD, FRCPC (biography and disclosures) Update September 23, 2010: The FDA has announced severe restrictions on the access to Avandia in the United States. Current users of Avandia who are...
View Article
/fit-in/580x348/filters:format(webp)/english-betterindia/media/media_files/2026/09/30/project-neev-rural-education-2026-09-30-12-47-52.png)